CV Sciences, Inc. (OTC: CVSI)

CV Sciences, Inc. is a consumer wellness company focused on nutraceuticals and plant-based foods, leveraging hemp extracts and science-backed natural ingredients. The company operates in the rapidly growing health and wellness sector, specializing in the development, manufacturing, and distribution of hemp-derived cannabidiol (CBD) products, as well as plant-based protein alternatives. With a commitment to research and quality, CV Sciences positions itself as a leader in the natural products market, offering solutions that cater to health-conscious consumers seeking functional and sustainable options.

The company generates revenue through the sale of its proprietary brands, including +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox. These products are marketed across multiple channels, including business-to-business (B2B) and business-to-consumer (B2C) platforms. Primary revenue streams stem from hemp extract supplements, plant-based foods, and contract manufacturing services for softgels and tinctures. The company’s portfolio spans softgels, tinctures, topicals, gummies, and plant-based protein products, sold through online platforms, retail stores, distributors, and e-commerce partners. In 2025, 39% of net revenue was derived from new products launched since 2023, reflecting a strong pipeline of innovation.

The company operates through the following segments:

• +PlusCBD: This segment represents the flagship brand, offering a comprehensive line of hemp-derived CBD products, including softgels, tinctures, topicals, and gummies. +PlusCBD is the top-selling hemp extract brand in the U. S. natural products market, backed by clinical research, third-party safety testing, and self-affirmed Generally Recognized as Safe (GRAS) status. The brand also includes a pet-specific line, formulated for cats and dogs, available in chews and liquids with flavors like beef and chicken.

• +PlusHLTH: Launched in 2024, this segment focuses on cannabinoid-free supplements designed to enhance health, performance, and vitality. Products under this brand are distributed to select U. S. retailers and sold online, targeting consumers seeking natural, non-CBD wellness solutions.

• Cultured Foods: This segment encompasses the company’s plant-based protein products, primarily distributed in Europe. The brand offers 100% plant-based, gluten-free, and shelf-stable food alternatives, catering to vegan, flexitarian, and health-focused consumers. Cultured Foods operates through a wholly owned subsidiary based in Poland, serving as a key manufacturing and distribution hub for the European market.

• Lunar Fox: Introduced in 2025, this segment features plant-based, gluten-free, and shelf-stable products tailored for the U. S. market. Lunar Fox expands the company’s footprint in the plant-based food sector, complementing the Cultured Foods brand with a focus on natural and nutritious alternatives.

• Contract Manufacturing: Through its acquisition of Elevated Softgels, CV Sciences provides encapsulated softgel and tincture manufacturing services for the supplement and nutrition industry. The company supports low to large minimum order quantities, offering formulation assistance and third-party lab testing to ensure product purity and potency.

CV Sciences holds a prominent position in the competitive CBD and plant-based food industries, distinguished by its research-driven approach and market leadership. In the U. S. natural products market, +PlusCBD is the top-selling hemp extract brand, according to SPINS, a leading provider of syndicated data for the industry. The company’s competitive advantages include published clinical research supporting product efficacy, rigorous quality standards, and a robust intellectual property portfolio, including patents for CBD-based therapeutic applications. However, the CBD market remains highly fragmented, with competitors such as Charlotte’s Web Holdings, cbdMD, and Medterra CBD vying for market share. In the plant-based food sector, CV Sciences competes in a similarly fragmented European market, where its shelf-stable, gluten-free offerings differentiate it from refrigerated alternatives. The company’s ability to handle small and large manufacturing orders further strengthens its position in contract manufacturing, appealing to brands seeking flexibility and scalability.

The company serves a diverse customer base, including retail consumers, brick-and-mortar stores, e-commerce platforms, and distributors. In 2025, products were sold in approximately 2,500 physical retail locations across the U. S., alongside online sales through the company’s websites and third-party e-tailers. The plant-based food segment primarily targets European distributors and retailers, with a focus on developed markets in Northern and Western Europe. No single customer accounted for more than 8% of total sales in 2025, indicating a well-diversified revenue stream. The company’s products appeal to health-conscious individuals, pet owners, and consumers seeking plant-based or functional wellness solutions.